Literature DB >> 21931274

Aberrant hypermethylation of miR-9 genes in gastric cancer.

Kuo-Wang Tsai1, Yu-Lun Liao, Chew-Wun Wu, Ling-Yueh Hu, Sung-Chou Li, Wen-Ching Chan, Meng-Ru Ho, Chun-Hung Lai, Hsiao-Wei Kao, Wen-Liang Fang, Kuo-Hung Huang, Wen-chang Lin.   

Abstract

Carcinogenesis of the stomach involves multiple steps including genetic mutation or epigenetic alteration of tumor suppressor genes or oncogenes. Recently, tumor suppressive miRNAs have been shown to be deregulated by aberrant hypermethylation during gastric cancer progression. In this study, we demonstrate that three independent genetic loci encoding for miR-9 (miR-9-1, miR-9-2 and miR-9-3) are simultaneously modified by DNA methylation in gastric cancer cells. Methylation-mediated silencing of these three miR-9 genes can be reactivated in gastric cancer cells through 5-Aza-dC treatment. Subsequent analysis of the expression levels of miR-9 showed that it was significantly down-regulated in gastric cancers compared with adjacent normal tissues (P value < 0.005). A similar tendency toward a tumor-specific DNA methylation pattern was shown for miR-9-1, miR-9-2 and miR-9-3 in 72 primary human gastric cancer specimens. Ectopic expression of miR-9 inhibited cell proliferation, migration and invasion, suggesting its tumor suppressive potential in gastric cancer progression.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21931274      PMCID: PMC3225840          DOI: 10.4161/epi.6.10.16535

Source DB:  PubMed          Journal:  Epigenetics        ISSN: 1559-2294            Impact factor:   4.528


  37 in total

1.  miR-199a regulates the tumor suppressor mitogen-activated protein kinase kinase kinase 11 in gastric cancer.

Authors:  Guang Song; Huazong Zeng; Jian Li; Lifeng Xiao; Yingzi He; Yinhua Tang; Yuru Li
Journal:  Biol Pharm Bull       Date:  2010       Impact factor: 2.233

Review 2.  DNA methylation as a marker for the past and future.

Authors:  Toshikazu Ushijima; Takeshi Nakajima; Takao Maekita
Journal:  J Gastroenterol       Date:  2006-05       Impact factor: 7.527

3.  Downregulation of microRNA-200 in EBV-associated gastric carcinoma.

Authors:  Aya Shinozaki; Takashi Sakatani; Tetsuo Ushiku; Rumi Hino; Maya Isogai; Shunpei Ishikawa; Hiroshi Uozaki; Kenzo Takada; Masashi Fukayama
Journal:  Cancer Res       Date:  2010-05-18       Impact factor: 12.701

4.  NF-κB targets miR-16 and miR-21 in gastric cancer: involvement of prostaglandin E receptors.

Authors:  Vivian Y Shin; Hongchuan Jin; Enders K O Ng; Alfred S L Cheng; Wilson W S Chong; Christine Y P Wong; Wai K Leung; Joseph J Y Sung; Kent-Man Chu
Journal:  Carcinogenesis       Date:  2010-11-15       Impact factor: 4.944

5.  MicroRNA-101 is down-regulated in gastric cancer and involved in cell migration and invasion.

Authors:  Hui-Ju Wang; Hong-Jun Ruan; Xu-Jun He; Ying-Yu Ma; Xiao-Ting Jiang; Ying-Jie Xia; Zai-Yuan Ye; Hou-Quan Tao
Journal:  Eur J Cancer       Date:  2010-08       Impact factor: 9.162

6.  Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer.

Authors:  U Lehmann; B Hasemeier; M Christgen; M Müller; D Römermann; F Länger; H Kreipe
Journal:  J Pathol       Date:  2008-01       Impact factor: 7.996

7.  Xenoestrogen-induced epigenetic repression of microRNA-9-3 in breast epithelial cells.

Authors:  Pei-Yin Hsu; Daniel E Deatherage; Benjamin A T Rodriguez; Sandya Liyanarachchi; Yu-I Weng; Tao Zuo; Joseph Liu; Alfred S L Cheng; Tim H-M Huang
Journal:  Cancer Res       Date:  2009-06-23       Impact factor: 12.701

8.  MicroRNA-148b is frequently down-regulated in gastric cancer and acts as a tumor suppressor by inhibiting cell proliferation.

Authors:  Yong-Xi Song; Zhen-Yu Yue; Zhen-Ning Wang; Ying-Ying Xu; Yang Luo; Hui-Mian Xu; Xue Zhang; Li Jiang; Cheng-Zhong Xing; Yong Zhang
Journal:  Mol Cancer       Date:  2011-01-04       Impact factor: 27.401

9.  Down-regulated miR-9 and miR-433 in human gastric carcinoma.

Authors:  Hongchun Luo; Hongbin Zhang; Zhenzhen Zhang; Xia Zhang; Bo Ning; Jinjun Guo; Na Nie; Bo Liu; Xiaoling Wu
Journal:  J Exp Clin Cancer Res       Date:  2009-06-16

10.  microRNAs and genetic diseases.

Authors:  Nicola Meola; Vincenzo Alessandro Gennarino; Sandro Banfi
Journal:  Pathogenetics       Date:  2009-11-04
View more
  58 in total

1.  Epithelial stem cell mutations that promote squamous cell carcinoma metastasis.

Authors:  Ruth A White; Jill M Neiman; Anand Reddi; Gangwen Han; Stanca Birlea; Doyel Mitra; Laikuan Dionne; Pam Fernandez; Kazutoshi Murao; Li Bian; Stephen B Keysar; Nathaniel B Goldstein; Ningjing Song; Sophia Bornstein; Zheyi Han; Xian Lu; Joshua Wisell; Fulun Li; John Song; Shi-Long Lu; Antonio Jimeno; Dennis R Roop; Xiao-Jing Wang
Journal:  J Clin Invest       Date:  2013-09-03       Impact factor: 14.808

Review 2.  MicroRNAs in tumorigenesis, metastasis, diagnosis and prognosis of gastric cancer.

Authors:  C Jiang; X Chen; M Alattar; J Wei; H Liu
Journal:  Cancer Gene Ther       Date:  2015-05-22       Impact factor: 5.987

3.  Sulforaphane epigenetically demethylates the CpG sites of the miR-9-3 promoter and reactivates miR-9-3 expression in human lung cancer A549 cells.

Authors:  Linbo Gao; David Cheng; Jie Yang; Renyi Wu; Wenji Li; Ah-Ng Kong
Journal:  J Nutr Biochem       Date:  2018-02-09       Impact factor: 6.048

4.  Cadherin-6 is a putative tumor suppressor and target of epigenetically dysregulated miR-429 in cholangiocarcinoma.

Authors:  Benjamin Goeppert; Christina Ernst; Constance Baer; Stephanie Roessler; Marcus Renner; Arianeb Mehrabi; Mohammadreza Hafezi; Anita Pathil; Arne Warth; Albrecht Stenzinger; Wilko Weichert; Marion Bähr; Rainer Will; Peter Schirmacher; Christoph Plass; Dieter Weichenhan
Journal:  Epigenetics       Date:  2016-09-03       Impact factor: 4.528

Review 5.  Epigenetic Mechanisms and Events in Gastric Cancer-Emerging Novel Biomarkers.

Authors:  Hasan Raza Kazmi; Soni Kumari; Satendra Tiwari; A Khanna; Gopeshwar Narayan
Journal:  Pathol Oncol Res       Date:  2018-03-19       Impact factor: 3.201

6.  Iodine-125 irradiation inhibits invasion of gastric cancer cells by reactivating microRNA-181c expression.

Authors:  Yong Yang; Zhen-Huan Ma; Xiao-Gang Li; Wan-Fu Zhang; Jia Wan; Ling-Juan Du; Guo-Jian Li; Guo-Kai Yang; Ping Lu
Journal:  Oncol Lett       Date:  2016-08-17       Impact factor: 2.967

7.  MicroRNA 9-3p targets β1 integrin to sensitize claudin-low breast cancer cells to MEK inhibition.

Authors:  Jon S Zawistowski; Kazuhiro Nakamura; Joel S Parker; Deborah A Granger; Brian T Golitz; Gary L Johnson
Journal:  Mol Cell Biol       Date:  2013-03-25       Impact factor: 4.272

Review 8.  DNA methylation and microRNA dysregulation in cancer.

Authors:  Hiromu Suzuki; Reo Maruyama; Eiichiro Yamamoto; Masahiro Kai
Journal:  Mol Oncol       Date:  2012-08-10       Impact factor: 6.603

9.  miR-9a minimizes the phenotypic impact of genomic diversity by buffering a transcription factor.

Authors:  Justin J Cassidy; Aashish R Jha; Diana M Posadas; Ritika Giri; Koen J T Venken; Jingran Ji; Hongmei Jiang; Hugo J Bellen; Kevin P White; Richard W Carthew
Journal:  Cell       Date:  2013-12-19       Impact factor: 41.582

10.  MicroRNA-9 is a ponderable index for the prognosis of human hepatocellular carcinoma.

Authors:  Jingchang Sun; Kunpeng Fang; Hang Shen; Yeben Qian
Journal:  Int J Clin Exp Med       Date:  2015-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.